Comparison of Whole Body DWI to FDG PET

Recruiting now · Not applicable

Conditions studied: Metastatic Cancer

In brief

This is a single arm prospective trial that evaluates whole body diffusion weight imaging (DWI) compared to 18F-fludeoxyglucose (FDG) Positron Emission Tomography with Magnetic resonance imaging (PET/MRI) in participants with known metastatic cancer.

Key facts

Study ID

NCT06630845

Run by

University of California, San Francisco

People needed

30

Starts

2025-02-06

Expected to finish

2029-10-31

Last updated by the study team

2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years.
• Non FDG PET imaging study scheduled to be performed within 60 days (before or after) of the research PET/MRI.
• Ability to understand a written informed consent document, and the willingness to sign it.
• Diagnosis of metastatic cancer.

You may not qualify if…

• Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.
• Individuals with contraindications to MRI. This will be determined through review of the UCSF MRI screening form by qualified site personnel

Where it is running

• University of California, San Francisco — San Francisco, California, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.